Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lactobacillus GG for Wheeze and Allergic Sensitization in Infants
NCT00490425Phase 4Completed
- Sponsor
- Universitätsklinikum Frankfurt
- Start
- Oct 2002
- Modality
- Live Biotherapeutic Products
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in allergic asthma comparing Lactobacillus GG with Placebo (2 arms). Primary endpoints: Episodes of wheezing at 12 months, Use of rescue medication at 12 months and 2 more. Started Oct 2002; status: completed.
02
Drugs
Lactobacillus rhamnosus GG
03
Conditions
allergic asthma
Beyond the preview
Go deeper on NCT00490425.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00490425.